PUBLICATIONS

Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation system

No.75
Year2020
JournalBlood Adv
InstituteHamamatsu University School of Medicine
1st AuthorY Suzuki
AR〇 (240/s)
PL
HD
Paper typesBasic research
Main
purpose
Evaluation of the role of thrombin-activatable fibrinolysis inhibitor (TAFI)
Disease
Antiplatelet drug
Anticoagulant drug
Other drugtPA, TAFIa inhibitor
Clinical specimens
Animal
Keywordtissue-type plasminogen activator, tPA, thrombin-activatable fibrinolysis inhibitor, TAFI
PL Chip for T-TAS01 is available for in vitro diagnostic use only in the the United States and EU Copyright © 2020 FUJIMORI KOGYO CO.,LTD. All Rights Reserved.